<?xml version="1.0" ?>
<text author="Jiande Wu, Tarun  Karthik Kumar Mamidi, Lu Zhang, Chindo Hicks" dateCollected="2019-11-03" id="autogum_academic_doc462" shortTile="deconvolution-genomic" sourceURL="https://www.mdpi.com/2072-6694/11/11/1692/htm" speakerCount="0" speakerList="none" title="Deconvolution of the Genomic and Epigenomic Interaction Landscape of Triple-Negative Breast Cancer" type="academic">
<head>
<s>
1
.
</s>
<s>
Introduction
</s>
</head>
<p>
<s>
Triple-negative
breast
cancer
(
TNBC
)
is
a
heterogeneous
disease
,
characterized
by
aggressive
clinical
behavior
,
poor
prognosis
,
a
significantly
increased
risk
of
relapse
,
and
shorter
survival
rates
than
patients
affected
by
other
molecular
subtypes
of
breast
cancer
.
</s>
<s>
TNBC
is
clinically
defined
as
tumors
that
lack
expression
of
the
estrogen
receptor
(
ER
)
,
progesterone
receptor
(
PR
)
,
and
HER2
amplification
.
</s>
<s>
It
affects
primarily
younger
premenopausal
women
and
tends
to
have
higher
incidences
in
African
American
women
,
although
recent
studies
reported
no
differences
in
clinical
outcomes
between
Caucasian
and
African
American
women
after
adjusting
for
socioeconomic
factors
.
</s>
<s>
Currently
,
there
are
no
effective
targeted
therapies
.
</s>
<s>
Cytotoxic
chemotherapy
remains
the
only
effective
therapeutic
modality
for
this
aggressive
and
often
lethal
type
of
breast
cancer
.
</s>
<s>
Therefore
,
there
is
an
urgent
need
for
the
discovery
of
molecular
markers
and
targets
for
the
development
of
novel
targeted
therapeutics
.
</s>
</p>
<p>
<s>
Our
understanding
of
the
molecular
basis
of
TNBC
and
development
of
effective
targeted
therapies
has
been
hampered
by
the
complexity
and
multifactorial
etiology
of
the
disease
.
</s>
<s>
Genes
play
a
major
role
in
the
pathogenesis
of
TNBC
.
</s>
<s>
The
majority
of
TNBC
patients
carry
mutations
in
the
highly
penetrant
cancer
susceptibility
genes
BRCA1
and
BRCA2
.
</s>
<s>
In
unselected
TNBC
cases
,
the
prevalence
of
pathogenic
germline
<hi rend="italic">
BRCA1
</hi>
and
<hi rend="italic">
BRCA2
</hi>
mutations
is
approximately
twice
as
high
as
in
breast
cancer
overall
.
</s>
<s>
Apart
from
<hi rend="italic">
BRCA1
</hi>
and
<hi rend="italic">
BRCA2
</hi>
,
the
rarely
mutated
breast
cancer
predisposition
genes
<hi rend="italic">
PALB2
</hi>
and
<hi rend="italic">
FANCM
</hi>
have
been
associated
with
TNBC
.
</s>
<s>
Multigene
panel
testing
has
also
identified
genes
with
high
and
moderate
penetrance
associated
with
an
increased
risk
of
developing
TNBC
.
</s>
<s>
However
,
although
genes
may
play
a
strong
role
,
molecular
epidemiology
studies
suggest
that
TNBC
risk
is
largely
determined
by
interactions
between
genes
and
environment
.
</s>
<s>
Increased
attention
has
focused
on
epigenetic
variation
such
as
DNA
methylation
and
TNBC
because
enduring
epigenetic
landmarks
define
the
tumor
microenvironment
.
</s>
<s>
Moreover
,
because
DNA
methylation
regulates
gene
expression
,
aberrant
methylated
genes
could
serve
as
complementary
diagnostic
tools
,
prognostic
markers
and
predictors
of
response
to
treatment
.
</s>
<s>
Thus
,
a
critical
knowledge
gap
,
and
an
unmet
medical
need
,
is
understanding
the
interplay
between
genetic
(
both
germline
and
somatic
)
variation
and
epigenomic
variation
in
TNBC
.
</s>
</p>
<p>
<s>
Advances
in
microarray
technology
have
enabled
molecular
classification
of
subtypes
of
TNBC
.
</s>
<s>
At
least
,
several
clinically
validated
prognostic
assays
including
the
Prosigna
PAM50
,
MammaPrint
and
Oncotype
DX
,
have
been
developed
using
transcription
profiling
.
</s>
<s>
However
,
although
these
primary
analyses
have
been
successful
in
identifying
prognostic
markers
,
they
have
been
unsuccessful
in
establishing
the
causal
association
between
gene
expression
and
the
disease
.
</s>
<s>
High-throughput
genotyping
using
genome-wide
association
studies
(
GWAS
)
has
enabled
discovery
of
genetic
variants
associated
with
an
increased
risk
of
developing
TNBC
.
</s>
<s>
The
recent
surge
of
next
generation
sequencing
of
tumor
genomes
by
large
multicenter
projects
,
such
as
The
Cancer
Genome
Atlas
(
TCGA
)
and
the
International
Cancer
Genome
Consortium
(
ICGC
)
,
have
generated
comprehensive
catalogues
of
somatic
mutations
associated
with
TNBC
.
</s>
<s>
The
clonal
and
mutational
spectrum
of
primary
TNBCs
have
also
been
characterized
.
</s>
<s>
We
recently
reported
oncogenic
interactions
between
genes
containing
germline
and
somatic
mutations
in
TNBC
.
</s>
</p>
<p>
<s>
However
,
to
date
,
information
on
germline
,
somatic
and
gene
expression
variation
has
not
been
leveraged
and
integrated
with
DNA
methylation
data
to
map
the
interplay
between
genetic
and
epigenetic
variation
in
TNBC
.
</s>
<s>
This
limited
progress
must
be
balanced
against
the
recognition
that
genomic
and
epigenomic
alterations
have
long
been
considered
as
two
separate
molecular
mechanisms
participating
in
TNBC
pathogenesis
.
</s>
<s>
The
objective
of
this
investigation
is
to
deconvolute
the
genomic
and
epigenomic
interaction
landscape
,
and
to
discover
and
characterize
the
molecular
networks
and
signaling
pathways
perturbed
by
these
interactions
in
TNBC
.
</s>
<s>
Our
working
hypothesis
was
that
TNBC
originates
from
a
complex
interplay
between
genomic
(
both
germline
and
somatic
)
variation
and
epigenomic
variations
.
</s>
<s>
We
further
hypothesized
that
these
complex
arrays
of
interacting
genomic
and
epigenomic
factors
affect
entire
molecular
networks
and
signaling
pathways
which
,
in
turn
,
drive
TNBC
.
</s>
<s>
We
addressed
these
hypotheses
by
integrating
information
on
germline
variation
from
GWAS
with
information
on
somatic
and
epigenomic
variation
from
TCGA
using
gene
expression
as
the
intermediated
phenotype
.
</s>
</p>
</text>
